Clinical Trial Update: Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing endothelial function in prostate cancer patients treated with degarelix versus LHRH agonists; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Prostatic Neoplasms

Drugs mentioned

• degarelix (degarelix)

Snippet

Sponsor: Rabin Medical Center | Conditions: Prostatic Neoplasms, Cardiovascular Diseases | Phase 4 | Status: COMPLETED